Skip to content

Clinical trials

Major Depressive Disorder trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Bulgaria Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20062
20071
20081
20091
20102
20123
20131
20142
20164
20174
20183
20207
20214
20225
20233
20244
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting8
Terminated6
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC12
H. Lundbeck A/S7
Intra-Cellular Therapies, Inc.5
Neurocrine Biosciences4
AstraZeneca3
GlaxoSmithKline3
Alkermes, Inc.2
Boehringer Ingelheim2
Corcept Therapeutics2
Neumora Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder59
Depressive Disorder6
Anhedonia4
Anxiety Disorders3
Depressive Disorder, Treatment-Resistant2
Mental Disorders2
Mood Disorders2
Psychotic Disorders2
Bipolar Disorder1
Psychomotor Disorders1

Trials

Showing 76 to 59 of 59. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.